| 1 |
29902719 | Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors. | 2018 Jul 15 |
1 |
| 2 |
26238995 | Label-free LC-MS analysis of HER2+ breast cancer cell line response to HER2 inhibitor treatment. | 2015 Aug 4 |
1 |
| 3 |
24191259 | Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells. | 2014 Jan |
1 |
| 4 |
24468788 | New chemical scaffolds for human african trypanosomiasis lead discovery from a screen of tyrosine kinase inhibitor drugs. | 2014 |
2 |
| 5 |
23375200 | Lapatinib inhibits meiotic maturation of porcine oocyte-cumulus complexes cultured in vitro in gonadotropin-supplemented medium. | 2013 May |
2 |
| 6 |
22370628 | Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence. | 2012 Jun |
1 |